Elanra Ionisers

The Elanra Ioniser is made in Australia where it is classified by the Australian Health Department as a therapeutic device (Aust.L12832; Product No. 62365). It is the only ioniser anywhere in the world to be classified as such and to be patented as a medical device.

The crucial difference between the Elanra and any other ioniser in the World is that the Elanra produces small ingestible negative ions (replicating the Earth's natural ions) consistently and over a greater range than any other ioniser in the world. This is important, because it is these small negative ions that have by far the greatest impact on your health. This concept, and what it means for your health, is fully explained in our other web site which is dedicated entirely to the Elanra products, www.elanra.co.uk. Most other ionisers are simply air cleaners and do not cocnsitently produce biologically active ions over a meaningful range.

On our dedicated Elanra site you will find many moving letters from thankful owners and lot's of other useful information such as magazine articles, research papers and a wealth of other information on negative ions and the improvements they can bring to our health and general well being.

Thousands of individuals in the UK, Australia, Japan and the USA have had the benefit of using the Elanra Ionisers in recent years. The Elanra Ioniser products are only available in the UK through Aircare Systems Ltd.

Visit www.elanra.co.uk now and find out more about what is probably one of the world's greatest health breakthroughs.

Below is a list of the elanra ioniser products that we carry.

Ioniser Case Study

NHS sponsored research At St James’ Hospital, Leeds in conjunction with the University of Leeds – Using Air Ion Technologies products. Conducted on 2 January 2003.

New weapon to fight hospital infections

A potential new weapon in the fight against hospital acquired infections has been discovered by researchers at the University of Leeds.

The scientists studied the effect of negative air ionisers on infections caused by acinetobacter; a pathogen responsible for increasing numbers of sometimes fatal infections amongst hospital patients. The ionisers, manufactured by Hampshire-based Air Ion Technologies, were placed in the intensive care unit at St James's University Hospital, which, like similar wards across the UK, has had recurrent problems with infections caused by acinetobacter.

For the first six months the researchers, from the aerobiological research group in the University’s school of civil engineering, monitored the normal situation in the unit, taking samples from surfaces, patients and from the air to monitor bacteria levels, and logging the number of patient infections. During the second half of the year-long trial, the ionisers were switched on, and the results were impressive: infections due to acinetobacter reduced dramatically.

Lead researcher Dr Clive Beggs said: "This is the first epidemiological study of its kind into the use of ionisers in hospital wards and the initial results are very promising. We believe that the negative air ions are removing the bacteria from the air, so stopping the transmission of infection. Our tests have focused solely on acinetobacter, but it’s possible the ionisers may have had an effect on other airborne bacteria. We now need to carry out further research to determine exactly how the ions work and how widespread their effects could be."

Even without further research, the fact the ionisers are already making a difference is good enough for lead consultant at St James's intensive care unit, Dr Stephen Dean. "We wanted to be involved in the trial as infections are a major issue for units such as ours, where many patients are already very vulnerable," he said. "The results have been fantastic - so much so that we asked the University to leave the ionisers with us. Since the trial finished in May, we've kept them in operation, and have continued to see greatly reduced acinetobacter infections on the ward."

Dr Kevin Kerr, lead clinical microbiologist on the project, said: “Acinetobacter infections are very difficult to treat as the bacterium is resistant to nearly all antibiotics, so prevention of these infections is of key importance. Ionisers may become a powerful weapon in the fight against hospital-acquired infection.”

The researchers have compiled their report for NHS Estates who funded the study, and will be publishing a paper on the research. They are continuing their work on negative air ions and are conducting further trials and experiments at the University of Leeds

Product Categories: Humidifiers | Dehumidifiers | Articles | Air Conditioners | Air Fresheners | Air Purifiers
Ambient Scenting | Dehumidifiers UK #2 | Evaporative Coolers | Humidifiers UK #2 | Instruments and Controls | Ionisers
Odour Removal | Ozone Generators

Product Range: Airomatic System | Elanra Ioniser | Defensor | Prolitec

Businesses: Airports | Casino | Conference Centre | Dentist/Doctor | Entertainment | Food Production | Hospitals
Hotels | Hydroponics | Industrial | Laboratory | Museums & Attractions | Nightclubs | Office | Pubs